Recital 9, Regulation (EU) 2024/324

In forcesince 19 Jan 2024

For the active substance fluazinam, the Authority requested the submission of additional information for the purposes of assessment of the approval criteria set out in points 3.6.5 and 3.8.2 of Annex II to Regulation (EC) No 1107/2009, pursuant to Article 13(3a), first subparagraph, of Implementing Regulation (EU) No 844/2012, with a deadline of 17 December 2023.